Genetic predisposition to multiple sclerosis (MS) only explains a fraction of the disease risk;
lifestyle and environmental factors are key contributors to the risk of MS. Importantly, these …

Recent magnetic resonance (MR) studies of multiple sclerosis lesions indicate that axonal
injury is a major correlate of permanent clinical deficit. In the present study we systematically …

Background Progressive supranuclear palsy (PSP) is difficult to diagnose accurately. The
recently developed tau PET tracers may improve the diagnostic work‐up of PSP. Methods …

Background Teriflunomide is a new oral disease-modifying therapy for relapsing forms of
multiple sclerosis. Methods We concluded a randomized trial involving 1088 patients with …

Background: Multiple sclerosis (MS) is a complex disease with new drugs becoming
available in the past years. There is a need for a reference tool compiling current data to aid …

BACKGROUND: There is increasing evidence that, in addition to the well-known effects on
musculoskeletal health, vitamin D status may be related to a number of non-skeletal diseases…

Background Teriflunomide is an oral disease-modifying therapy approved for treatment of
relapsing or relapsing–remitting multiple sclerosis. We aimed to provide further evidence for …

Multiple sclerosis is a chronic inflammatory disease characterized by perivenous inflammation
and focal destruction of myelin. Many attempts have been undertaken previously to create …

Multiple sclerosis is a chronic, often disabling, disease of the central nervous system affecting
more than 1 in 1,000 people in most western countries. The inflammatory lesions typical of …

Importance Neurofilament light protein (NfL) is elevated in cerebrospinal fluid (CSF) of a
number of neurological conditions compared with healthy controls (HC) and is a candidate …